GBI Research, Feb 2010, Pages: 89
company’s growth by understanding the new growth opportunities for RFID technologies within the pharmaceutical market
- Draft efficient strategies by understanding bestpractices, identifying key winners
CBR Pharma Insights, Aug 2010
- Biggest users of social media
- Innovators
- Benchmarking bestpractices in social media image development
The future impact of social media and the internet on pharmaceutical marketing
- Expert
CBR Pharma Insights, April 2011, Pages: 49
for product marketing in pharma, this report covers various factors for consideration. Several product launch scenarios are included to provide insight into bestpractices and successful strategies and tactics
Frost & Sullivan, March 2011, Pages: 63
various perspectives such as global, technology, economic, customers, industry, competition and bestpractices. In this research, Frost & Sullivan's expert analysts thoroughly examine the opportunity
GBI Research, June 2011, Pages: 95
against counterfeiting of drugs
- Identify bestpractices in the industry through analyses of solutions developed by industry leaders
- Strengthen security of supply chain through case studies
Markets and Markets, Aug 2010, Pages: 146
reports provide market breakdown upto level 5.
- 15 pages of high level analysis including benchmarking strategies, bestpractices and the market’s cash cows (BCG matrix). We conduct detailed
GBI Research, May 2010, Pages: 82
&D practices at the global level in order to improve its efficiency and effectiveness. This pharmaceutical and healthcare report provides comprehensive insight into the major challenges in the current
Euromoney Trading Ltd, Feb 2012
techniques and bestpractice strategies.
- Industry Focus – how individual corporations and different industry sectors such as biotech, IT & telecoms and pharmaceuticals exploit and protect IP rights and how
Decision Resources, Inc., May 2008, Pages: 30
a radical change in Italian pharmaceutical policy, the industry’s competitiveness in the global market will be severely compromised, and Italy will soon be overtaken in the global rankings by other major
Business Insights, Jan 2006, Pages: 163
into the bestpractices of leaders at the forefront of shaping pharmaceutical industry branding. The report provides expert analysis on key branding issues and their impact on DTC marketing, PR, corporate
Cutting Edge Information, Aug 2009, Pages: 123
system. Interviewed pharmaceutical executives discuss their strategic responses to potential changes that could be on the managed markets horizon. Cutting Edge Information's analysts designed the practices
Business Insights, Aug 2010, Pages: 174
and bestpractice.
Scope of this report
- Identify current and future trends in pharmaceutical industry employment and understand their causes.
- Assess inter-country (and within the US inter-state
The Signal Group, April 2010, Pages: 109
services strategically
- Understand bestpractices
- Position your organization and offering
- Forecast demand
Key Questions Answered:
- Where are the opportunities?
- Is the market maturing?
- Where
Strategic Consulting Inc, Aug 2010, Pages: 140
New Market Report States Rapid Microbiological Method Usage In Pharma and PCP Sectors Will Double!
According to this new market research report, the globalPharmaceutical (Pharma) and Personal Care
Business Insights, March 2006, Pages: 143
of product development and marketing. However, with no established ‘bestpractices’ in brand management, those tasked with steering brands around the various hurdles and challenges presented by pharmaceutical
Eularis, June 2011, Pages: 46
to be instrumental at the key moment of launch, and marketers are under extreme pressure. To deliver on the high hopes of Pharmaceutical brand launches, companies must engage in comprehensive pre-launch planning
Frost & Sullivan, July 2009, Pages: 54
This research service presents the CEO 360 Degree Perspective for the globalpharmaceuticals and biotechnology industry in 2009. It is an amalgamation of research from more than 50 Pharmaceutical
FirstWord Publishing, Aug 2011, Pages: 43
... Embracing CER is regarded as an essential step for the innovative pharmaceutical industry.”
– Marc L Berger, vice-president of global health outcomes and David Grainger, global public policy director, Eli
Decision Resources, Inc., June 2006, Pages: 18
In this report, we present the results of a study we performed in Europe in 2005 to identify bestpractices in marketing and sales strategies among high-performing and profitably growing biotech
Business Insights, Nov 2009, Pages: 145
growth pharmaceutical markets (Brazil, Russia, India and China)
- Successfully formulate and implement global pricing strategies in order to deliver local optimization and global coordination
- Deliver
